A Phase 1/2, Open-label, Parallel Group Study to Evaluate the Preliminary Efficacy and Usability DARE-HRT1 (80 μg Estradiol/4 mg Progesterone and 160 μg Estradiol/8 mg Progesterone Intravaginal Rings) Over 12 Weeks in Healthy Postmenopausal Women

被引：0
|
作者：
Thurman, Andrea R. [1 ]
Hull, Louise [2 ]
Stuckey, Bronwyn [3 ]
Hatheway, Jessica [1 ]
Zack, Nadene [1 ]
Mauck, Christine [1 ]
Friend, David R. [1 ]
机构：
[1] Dare Biosci, San Diego, CA USA
[2] Univ Adelaide, PARC Clin Res & Robinson Res Inst, Adelaide, SA, Australia
[3] Keogh Inst Med Res Inc, Nedlands, WA, Australia
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2023年 / 30卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-102
引用
收藏
页码：1300 / 1301
页数：2
相关论文
共 4 条
  • [1] A phase 1/2, open-label, parallel group study to evaluate the preliminary efficacy and usability DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal RinGSM) over 12 weeks in healthy postmenopausal women
    Thurman, Andrea
    Hull, M. Louise
    Stuckey, Bronwyn
    Hatheway, Jessica
    Zack, Nadene
    Mauck, Christine
    Friend, David
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (09): : 940 - 946
  • [2] A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women
    Thurman, Andrea
    Hull, M. Louise
    Stuckey, Bronwyn
    Hatheway, Jessica
    Zack, Nadene
    Mauck, Christine
    Friend, David
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (08): : 817 - 823
  • [3] A Phase 1/2, Open-label, Parallel Group Study of the Safety and Pharmacokinetics of DARE-HRT1 (80 μg Estradiol/4 mg Progesterone and 160 μg Estradiol/8 mg Progesterone Intravaginal Rings) Over 12 Weeks in Healthy Postmenopausal Women
    Thurman, Andrea R.
    Hull, Louise
    Stuckey, Bronwyn
    Hatheway, Jessica
    Zack, Nadene
    Mauck, Christine
    Friend, David R.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1300 - 1300
  • [4] Safety, Tolerability and Usability of Oral Estradiol (E2) and Progesterone (P4) versus Two Formulations of Dare HRT1, an Intravaginal Ring containing Bioidentical E2 and P4, in a First-In-Woman Phase I Study
    Mauck, Christine
    Hull, Louise
    Stuckey, Bronwyn
    Hartman, Kimberly A.
    Johnson, Sabrina M.
    Zack, Nadene
    Kiang, Jennifer
    Thurman, Andrea R.
    Friend, David
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (12): : 1487 - 1488
1